SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 29, 2004
ORTHOLOGIC CORP.
Delaware
| 000-21214 | 86-0585310 | |
| (Commission File Number) | (IRS Employer Identification Number) |
1275 West Washington Street, Tempe, Arizona 85281
Registrant’s telephone number, including area code: (602) 286-5520
Not Applicable
| Item 5. Results of Operations and Financial Condition | ||||||||
| Item 7. Financial Statements and Exhibits | ||||||||
| SIGNATURES | ||||||||
| INDEX TO EXHIBITS | ||||||||
| EX-99.1 | ||||||||
Item 5. Results of Operations and Financial Condition
On April 29, 2004, OrthoLogic Corp. issued a press release announcing that is has signed a definitive agreement to acquire substantially all of the assets and intellectual property of privately held Chrysalis BioTechnology, Inc., based in Galveston, Texas, for up to $34.5 million in cash and stock. A copy of the press release is attached as Exhibit 99.1 to this report.
Item 7. Financial Statements and Exhibits
(c) Exhibits
| Exhibit No. |
Description |
|
99.1
|
Press release, dated April 29, 2004, issued by OrthoLogic Corp. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: April 29, 2004
|
ORTHOLOGIC CORP. | |
| /s/ Thomas Trotter | ||
| Thomas Trotter | ||
| Chief Executive Officer |